HMGCS2 and metabolic dysfunction-associated steatotic liver disease: Mechanistically, BPS upregulated HMGCS2 in hepatocytes, and HMGCS2 knockdown reversed ferroptosis markers, demonstrating that HMGCS2-mediated ferroptosis drives BPS-aggravated NAFLD.